Investegate |Junshi Biosciences Announcements | Junshi Biosciences: Junshi Biosciences Announces Acceptance by NMPA of Investigational New Drug Application for the Subcutaneous Injection of Anti-BLyS Monoclonal Antibody : vimarsana.com

Investegate |Junshi Biosciences Announcements | Junshi Biosciences: Junshi Biosciences Announces Acceptance by NMPA of Investigational New Drug Application for the Subcutaneous Injection of Anti-BLyS Monoclonal Antibody

Investegate announcements from Junshi Biosciences, Junshi Biosciences Announces Acceptance by NMPA of Investigational New Drug Application for the Subcutaneous Injection of Anti-BLyS Monoclonal Antibody

Related Keywords

Guangzhou , Guangdong , China , Beijing , Maryland , United States , Shanghai , Suzhou , Jiangsu , San Francisco , California , Chinese , Junshi Biosciences , Zhi Li , Eli Lilly , Institute Of Microbiology Chinese Academy Science , Ir Team , Journal Of Arthritis Research Treatment , National Medical Products Administration , Pr Team , Junshi Biosciences Announces Acceptance , Investigational New Drug Application , Subcutaneous Injection , Systemic Lupus Erythematosus , Arthritis Research , Microbiology Chinese Academy , Emergency Use Authorization , Investegate Announcements , Nvestegate Company Announcements , Unshi Biosciences , Lobenewswire , Lobenewswire And Globenewswire , Nw ,